Abbvie Inc at Bank of America Global Healthcare Conference Transcript
Welcome to the BofA Healthcare Conference. My name is Geoff Meacham, I'm a senior biopharma analyst here at BofA. And we're happy to kick it off with AbbVie today.
So with me on stage, we have Rob Michael, Vice Chairman and President; Scott Reents, EVP, CFO; Jeff Stewart, EVP, CCO; and then Roopal Thakkar, who is SVP, Development, Regulatory Affairs and CMO. So guys, thanks for coming.
Thanks for having us.
Questions & Answers
Always a big crew, right? Rob, I'll kick it off to you. So when we talk about the cadence of this year, you guys have given pretty good specifics on the flow of earnings trough just with respect to the HUMIRA erosion. As you have moved through the year so far, what would you say is kind of better or worse than you thought initially? What are the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
